Prevalence of acne vulgaris among women with polycystic ovary syndrome: a systemic review and meta-analysis

References

• Bozdag G, Mumusoglu S, Zengin D, et al. The prevalence and phenotypic features of polycystic ovary syndrome: a systematic review and meta-analysis. Hum Reprod. 2016;31(12):2841–2855.
   PubMed Web of Science ®Google Scholar
• Behboudi-Gandevani S, Ramezani Tehrani F, Rostami Dovom M, et al. Insulin resistance in obesity and polycystic ovary syndrome: systematic review and meta-analysis of observational studies. Gynecol Endocrinol. 2016;32(5):343–353.
   PubMed Web of Science ®Google Scholar
• Behboudi-Gandevani S, Tehrani FR, Yarandi RB, et al. The association between polycystic ovary syndrome, obesity, and the serum concentration of adipokines. J Endocrinol Invest. 2017;40(8):859–866.
   PubMed Web of Science ®Google Scholar
• Amiri M, Tehrani FR, Bidhendi-Yarandi R, et al. Relationships between biochemical markers of hyperandrogenism and metabolic parameters in women with polycystic ovary syndrome: a systematic review and meta-analysis. Horm Metab Res. 2019;51(1):22–34.
   PubMed Web of Science ®Google Scholar
• Chuan SS, Chang RJ. Polycystic ovary syndrome and acne. Skin Ther Lett. 2010;15(10):1–4.
   PubMedGoogle Scholar
• Tehrani FR, Behboudi-Gandevani S, Simbar M, et al. A population-based study of the relationship between idiopathic hirsutism and metabolic disturbances. J Endocrinol Invest. 2015;38(2):155–162.
   PubMed Web of Science ®Google Scholar
• Azziz R, Carmina E, Dewailly D, et al. The Androgen Excess and PCOS Society criteria for the polycystic ovary syndrome: the complete task force report. Fertil Steril. 2009;91(2):456–488.
   PubMed Web of Science ®Google Scholar
• Vos T, Flaxman AD, Naghavi M, et al. Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012;380(9859):2163–2196.
   PubMed Web of Science ®Google Scholar
• Heng AHS, Chew FT. Systematic review of the epidemiology of acne vulgaris. Sci Rep. 2020;10(1):1–29.
   PubMed Web of Science ®Google Scholar
• Collier CN, Harper JC, Cantrell WC, et al. The prevalence of acne in adults 20 years and older. J Am Acad Dermatol. 2008;58(1):56–59.
   PubMed Web of Science ®Google Scholar
• Bhate K, Williams HC. Epidemiology of acne vulgaris. Br J Dermatol. 2013;168(3):474–485.
   PubMed Web of Science ®Google Scholar
• Arora MK, Yadav A, Saini V. Role of hormones in acne vulgaris. Clin Biochem. 2011;44(13):1035–1040.
   PubMed Web of Science ®Google Scholar
• Borgia F, Cannavò S, Guarneri F, et al. Correlation between endocrinological parameters and acne severity in adult women. Acta Derm Venereol. 2004;84(3):201–204.
   PubMed Web of Science ®Google Scholar
• Carmina E. Cutaneous manifestations of polycystic ovary syndrome. Curr Opinion Endocr Metab Res. 2020;8(2):104–110.
   Google Scholar
• Hajivandi L, Noroozi M, Mostafavi F, et al. Food habits in overweight and obese adolescent girls with polycystic ovary syndrome (PCOS): a qualitative study in Iran. BMC Pediatr. 2020;20(1):277.
   PubMed Web of Science ®Google Scholar
• Blay SL, Aguiar JV, Passos IC. Polycystic ovary syndrome and mental disorders: a systematic review and exploratory meta-analysis. Neuropsychiatr Dis Treat. 2016;12:2895–2903.
   PubMed Web of Science ®Google Scholar
• Dréno B. What is new in the pathophysiology of acne, an overview. J Eur Acad Dermatol Venereol. 2017;31(Suppl. 5):8–12.
   PubMed Web of Science ®Google Scholar
• Fauser BC, Tarlatzis BC, Rebar RW, et al. Consensus on women's health aspects of polycystic ovary syndrome (PCOS): the Amsterdam ESHRE/ASRM-Sponsored 3rd PCOS Consensus Workshop Group. Fertil Steril. 2012;97(1):28–38.e25.
   PubMed Web of Science ®Google Scholar
• Moher D, Liberati A, Tetzlaff J, et al. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLOS Med. 2009;6(7):e1000097.
   PubMed Web of Science ®Google Scholar
• Wells G, Shea B, Peterson J, et al. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. Ottawa Health Research Institute; 2009. Available from: http://www.ohri.ca/programs/clinical_epidemiology/oxford.htm.
   Google Scholar
• Moher DH, Schulz KF, Montori V, et al. CONSORT 2010 explanation and elaboration: updated guidelines for reporting parallel group randomised trials. Int J Surg. 2012;10(1):28–55.
   PubMed Web of Science ®Google Scholar
• Sterne JA, Hernán MA, Reeves BC, et al. ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions. BMJ. 2016;355:i4919.
   PubMed Web of Science ®Google Scholar
• Higgins JA, Gøtzsche PC, Jüni P, et al. The Cochrane Collaboration’s tool for assessing risk of bias in randomised trials. BMJ. 2011;343(2):d5928.
   PubMed Web of Science ®Google Scholar
• Bird ST, Hartzema AG, Brophy JM, et al. Risk of venous thromboembolism in women with polycystic ovary syndrome: a population-based matched cohort analysis. CMAJ. 2013;185(2):E115–E120.
   PubMed Web of Science ®Google Scholar
• Bird ST, Hartzema AG, Etminan M, et al. Polycystic ovary syndrome and combined oral contraceptive use: a comparison of clinical practice in the United States to treatment guidelines. Gynecol Endocrinol. 2013;29(4):365–369.
   PubMed Web of Science ®Google Scholar
• Esmaeilzadeh S, Delavar MA, Amiri M, et al. Polycystic ovary syndrome in Iranian adolescents. Int J Adolesc Med Health. 2014;26(4):559–565.
   PubMedGoogle Scholar
• Zhang J, Liu Y, Liu X, et al. High intake of energy and fat in Southwest Chinese women with PCOS: a population-based case-control study. PLOS One. 2015;10(5):e0127094.
   PubMed Web of Science ®Google Scholar
• Kumarendran B, Sumilo D, O’Reilly MW, et al. Increased risk of obstructive sleep apnoea in women with polycystic ovary syndrome: a population-based cohort study. Eur J Endocrinol. 2019;180(4):265–272.
   PubMed Web of Science ®Google Scholar
• Kumarendran B, O’Reilly MW, Manolopoulos KN, et al. Polycystic ovary syndrome, androgen excess, and the risk of nonalcoholic fatty liver disease in women: a longitudinal study based on a United Kingdom primary care database. PLOS Med. 2018;15(3):e1002542.
   PubMed Web of Science ®Google Scholar
• Tehrani FR, Rashidi H, Khomami MB, et al. The prevalence of metabolic disorders in various phenotypes of polycystic ovary syndrome: a community based study in Southwest of Iran. Reprod Biol Endocrinol. 2014;12(1):89.
   PubMedGoogle Scholar
• Ates S, Aydın S, Ozcan P, et al. Clinical and metabolic characteristics of Turkish adolescents with polycystic ovary syndrome. J Obstet Gynaecol. 2018;38(2):236–240.
   PubMedGoogle Scholar
• Hickey M, Sloboda D, Atkinson H, et al. The relationship between maternal and umbilical cord androgen levels and polycystic ovary syndrome in adolescence: a prospective cohort study. J Clin Endocrinol Metab. 2009;94(10):3714–3720.
   PubMed Web of Science ®Google Scholar
• Kaewnin J, Vallibhakara O, Arj-Ong Vallibhakara S, et al. Prevalence of polycystic ovary syndrome in Thai University adolescents. Gynecol Endocrinol. 2018;34(6):476–480.
   PubMed Web of Science ®Google Scholar
• Akram M, Roohi N. Endocrine correlates of polycystic ovary syndrome in Pakistani women. J Coll Physicians Surg Pak. 2015;25(1):22–26.
   PubMed Web of Science ®Google Scholar
• Belosi C, Selvaggi L, Apa R, et al. Is the PCOS diagnosis solved by ESHRE/ASRM 2003 consensus or could it include ultrasound examination of the ovarian stroma? Hum Reprod. 2006;21(12):3108–3115.
   PubMed Web of Science ®Google Scholar
• Cao NT, Le MT, Nguyen VQH, et al. Defining polycystic ovary syndrome phenotype in Vietnamese women. J Obstet Gynaecol Res. 2019;45(11):2209–2219.
   PubMed Web of Science ®Google Scholar
• Chen C-H, Wang P-H, Hsieh M-T, et al. Sexual orientations of women with polycystic ovary syndrome: clinical observation in Taiwan. Taiwan J Obstet Gynecol. 2014;53(4):542–546.
   PubMed Web of Science ®Google Scholar
• Ercan C, Coksuer H, Aydogan U, et al. Sexual dysfunction assessment and hormonal correlations in patients with polycystic ovary syndrome. Int J Impot Res. 2013;25(4):127–132.
   PubMed Web of Science ®Google Scholar
• Feng J, Guo Y, Ma L, et al. Prevalence of dermatologic manifestations and metabolic biomarkers in women with polycystic ovary syndrome in north China. J Cosmet Dermatol. 2018;17(3):511–517.
   PubMed Web of Science ®Google Scholar
• Hart K, Barr S, Reeves S, et al. Suboptimal dietary intake is associated with cardiometabolic risk factors in women with polycystic ovary syndrome. Nutr Diet. 2016;73(2):177–183.
   Web of Science ®Google Scholar
• Kazemi M, Pierson RA, Lujan ME, et al. Comprehensive evaluation of type 2 diabetes and cardiovascular disease risk profiles in reproductive-age women with polycystic ovary syndrome: a large Canadian cohort. J Obstet Gynaecol Can. 2019;41(10):1453–1460.
   PubMed Web of Science ®Google Scholar
• Lauritsen MP, Bentzen J, Pinborg A, et al. The prevalence of polycystic ovary syndrome in a normal population according to the Rotterdam criteria versus revised criteria including anti-Müllerian hormone. Hum Reprod. 2014;29(4):791–801.
   PubMed Web of Science ®Google Scholar
• Musmar S, Afaneh A, Mo'alla H. Epidemiology of polycystic ovary syndrome: a cross sectional study of university students at An-Najah National University-Palestine. Reprod Biol Endocrinol. 2013;11(1):47.
   PubMedGoogle Scholar
• Sharif E, Rahman S, Zia Y, et al. The frequency of polycystic ovary syndrome in young reproductive females in Qatar. Int J Womens Health. 2016;9:1–10.
   PubMed Web of Science ®Google Scholar
• Tan J, Wang Q-Y, Feng G-M, et al. Increased risk of psychiatric disorders in women with polycystic ovary syndrome in Southwest China. Chin Med J. 2017;130(3):262.
   PubMed Web of Science ®Google Scholar
• Al-Jefout M, Alnawaiseh N, Al-Qtaitat A. Insulin resistance and obesity among infertile women with different polycystic ovary syndrome phenotypes. Sci Rep. 2017;7(1):1–9.
   PubMedGoogle Scholar
• Erdoğan M, Karadeniz M, Alper G, et al. Thrombin-activatable fibrinolysis inhibitor and cardiovascular risk factors in polycystic ovary syndrome. Exp Clin Endocrinol Diabetes. 2008;116(03):143–147.
   PubMedGoogle Scholar
• Villarroel C, Trejo L, Muñoz A, et al. Assessment of diagnostic competence of plasmatic androgens on polycystic ovary syndrome based on receiver operator characteristic curves. Gynecol Endocrinol. 2010;26(8):600–606.
   PubMed Web of Science ®Google Scholar
• Welt C, Arason G, Gudmundsson J, et al. Defining constant versus variable phenotypic features of women with polycystic ovary syndrome using different ethnic groups and populations. J Clin Endocrinol Metab. 2006;91(11):4361–4368.
   PubMed Web of Science ®Google Scholar
• Welt C, Gudmundsson J, Arason G, et al. Characterizing discrete subsets of polycystic ovary syndrome as defined by the Rotterdam criteria: the impact of weight on phenotype and metabolic features. J Clin Endocrinol Metab. 2006;91(12):4842–4848.
   PubMed Web of Science ®Google Scholar
• Chun-Sen H, Chien-Hua W, Wan-Chun C, et al. Obesity and insulin resistance in women with polycystic ovary syndrome. Gynecol Endocrinol. 2011;27(5):300–306.
   PubMed Web of Science ®Google Scholar
• Köşüş N, Köşüş A, Turhan NÖ, et al. Do threshold values of ovarian volume and follicle number for diagnosing polycystic ovarian syndrome in Turkish women differ from western countries? Eur J Obstet Gynecol Reprod Biol. 2011;154(2):177–181.
   PubMed Web of Science ®Google Scholar
• Li L, Chen X, He Z, et al. Clinical and metabolic features of polycystic ovary syndrome among Chinese adolescents. J Pediatr Adolesc Gynecol. 2012;25(6):390–395.
   PubMed Web of Science ®Google Scholar
• Moini A, Eslami B. Familial associations between polycystic ovarian syndrome and common diseases. J Assist Reprod Genet. 2009;26(2–3):123–127.
   PubMed Web of Science ®Google Scholar
• Öztürk A, Kucur SK, Seven A, et al. Temperament and character differences of patients with polycystic ovary syndrome. J Gynecol Obstet Hum. 2019;48(4):255–259.
   Web of Science ®Google Scholar
• Rashid A, Bhat JA, Ganie MA, et al. Evaluation of serum anti-nuclear antibody among women with PCOS: a hospital based single center cross sectional study. Gynecol Endocrinol. 2018;34(11):965–969.
   PubMed Web of Science ®Google Scholar
• Schmidt TH, Khanijow K, Cedars MI, et al. Cutaneous findings and systemic associations in women with polycystic ovary syndrome. JAMA Dermatol. 2016;152(4):391–398.
   PubMed Web of Science ®Google Scholar
• Shabir I, Ganie MA, Praveen EP, et al. Morning plasma cortisol is low among obese women with polycystic ovary syndrome. Gynecol Endocrinol. 2013;29(12):1045–1047.
   PubMed Web of Science ®Google Scholar
• Shahrami SH, Ranjbar ZA, Milani F, et al. The relation between diverse phenotypes of PCOS with clinical manifestations, anthropometric indices and metabolic characteristics. Acta Med Iran. 2016;54:134–139.
   PubMedGoogle Scholar
• Sulaiman MA, Al-Farsi YM, Al-Khaduri MM, et al. Psychological burden among women with polycystic ovarian syndrome in Oman: a case-control study. Int J Womens Health. 2017;9:897–904.
   PubMed Web of Science ®Google Scholar
• Varanasi LC, Subasinghe A, Jayasinghe YL, et al. Polycystic ovarian syndrome: prevalence and impact on the wellbeing of Australian women aged 16–29 years. Aust N Z J Obstet Gynaecol. 2018;58(2):222–233.
   PubMed Web of Science ®Google Scholar
• Zhang H, Zhu F, Xiong J, et al. Characteristics of different phenotypes of polycystic ovary syndrome based on the Rotterdam criteria in a large-scale Chinese population. BJOG. 2009;116(12):1633–1639.
   PubMed Web of Science ®Google Scholar
• Zhao Y, Ruan X, Mueck AO. Clinical and laboratory indicators of polycystic ovary syndrome in Chinese Han nationality with different Rotterdam criteria-based phenotypes. Gynecol Endocrinol. 2016;32(2):151–156.
   PubMed Web of Science ®Google Scholar
• DeUgarte CM, Bartolucci AA, Azziz R. Prevalence of insulin resistance in the polycystic ovary syndrome using the homeostasis model assessment. Fertil Steril. 2005;83(5):1454–1460.
   PubMed Web of Science ®Google Scholar
• Hsu M-I, Liou T-H, Liang S-J, et al. Inappropriate gonadotropin secretion in polycystic ovary syndrome. Fertil Steril. 2009;91(4):1168–1174.
   PubMed Web of Science ®Google Scholar
• Lam P, Raine‐Fenning N, Cheung L, et al. Three-dimensional ultrasound features of the polycystic ovary in Chinese women. Ultrasound Obstet Gynecol. 2009;34(2):196–200.
   PubMed Web of Science ®Google Scholar
• Liou T-H, Yang J-H, Hsieh C-H, et al. Clinical and biochemical presentations of polycystic ovary syndrome among obese and nonobese women. Fertil Steril. 2009;92(6):1960–1965.
   PubMed Web of Science ®Google Scholar
• Roe AH, Prochaska E, Smith M, et al. Using the Androgen Excess–PCOS Society criteria to diagnose polycystic ovary syndrome and the risk of metabolic syndrome in adolescents. J Pediatr. 2013;162(5):937–941.
   PubMed Web of Science ®Google Scholar
• Sahin M, Demircioglu D, Oguz A, et al. Does insulin resistance increase thyroid volume in patients with polycystic ovary syndrome? Arch Endocrinol Metab. 2017;61(2):145–151.
   PubMed Web of Science ®Google Scholar
• Taponen S, Ahonkallio S, Martikainen H, et al. Prevalence of polycystic ovaries in women with self-reported symptoms of oligomenorrhoea and/or hirsutism: Northern Finland Birth Cohort 1966 Study. Hum Reprod. 2004;19(5):1083–1088.
   PubMed Web of Science ®Google Scholar
• Cankaya S, Demir B, Aksakal SE, et al. Insulin resistance and its relationship with high molecular weight adiponectin in adolescents with polycystic ovary syndrome and a maternal history of polycystic ovary syndrome. Fertil Steril. 2014;102(3):826–830.
   PubMed Web of Science ®Google Scholar
• Eser A, Erpolat S, Kaygusuz I, et al. Investigation of Demodex folliculorum frequency in patients with polycystic ovary syndrome. An Bras Dermatol. 2017;92(6):807–810.
   PubMed Web of Science ®Google Scholar
• Hosseini MS, Dizavi A, Rostami H, et al. Healthy eating index in women with polycystic ovary syndrome: a case-control study. Int J Reprod Biomed. 2017;15(9):575–582.
   PubMed Web of Science ®Google Scholar
• Mangalath AAM, Alias A, Sajith M, et al. Sociodemographic characteristics and clinical presentation of infertile women with polycystic ovary syndrome in a tertiary care hospital. Int J Infertil Fetal Med. 2018;9(1):14–18.
   Google Scholar
• Rashidi BH, Shams S, Shariat M, et al. Evaluation of serum hepcidin and iron levels in patients with PCOS: a case-control study. J Endocrinol Invest. 2017;40(7):779–784.
   PubMed Web of Science ®Google Scholar
• Shishehgar F, Mirmiran P, Rahmati M, et al. Does a restricted energy low glycemic index diet have a different effect on overweight women with or without polycystic ovary syndrome? BMC Endocr Disord. 2019;19(1):93.
   PubMed Web of Science ®Google Scholar
• Sulaiman MA, Al-Farsi YM, Al-Khaduri MM, et al. Polycystic ovarian syndrome is linked to increased oxidative stress in Omani women. Int J Womens Health. 2018;10:763–771.
   PubMed Web of Science ®Google Scholar
• Vural B, Caliskan E, Turkoz E, et al. Evaluation of metabolic syndrome frequency and premature carotid atherosclerosis in young women with polycystic ovary syndrome. Hum Reprod. 2005;20(9):2409–2413.
   PubMed Web of Science ®Google Scholar
• Zhang HY, Guo CX, Zhu FF, et al. Clinical characteristics, metabolic features, and phenotype of Chinese women with polycystic ovary syndrome: a large-scale case-control study. Arch Gynecol Obstet. 2013;287(3):525–531.
   PubMed Web of Science ®Google Scholar
• Anaforoglu I, Algun E, Incecayir O, et al. Higher metabolic risk with National Institutes of Health versus Rotterdam diagnostic criteria for polycystic ovarian syndrome in Turkish women. Metab Syndr Relat Disord. 2011;9(5):375–380.
   PubMed Web of Science ®Google Scholar
• Dalamaga M, Papadavid E, Basios G, et al. Ovarian SAHA syndrome is associated with a more insulin-resistant profile and represents an independent risk factor for glucose abnormalities in women with polycystic ovary syndrome: a prospective controlled study. J Am Acad Dermatol. 2013;69(6):922–930.
   PubMed Web of Science ®Google Scholar
• Jacob R, Jude K, Chandrasekhar R, et al. Prevalence of acne among women with poly cystic ovarian syndrome – a clinical study scrutiny. Int Res J Health Med Sci. 2014;1(1):7–13.
   Google Scholar
• Moran L, Gibson-Helm M, Teede H, et al. Polycystic ovary syndrome: a biopsychosocial understanding in young women to improve knowledge and treatment options. J Psychosom Obstet Gynaecol. 2010;31(1):24–31.
   PubMed Web of Science ®Google Scholar
• Behboudi-Gandevani S, Amiri M, Bidhendi Yarandi R, et al. The risk of metabolic syndrome in polycystic ovary syndrome: a systematic review and meta-analysis. Clin Endocrinol. 2018;88(2):169–184.
   PubMed Web of Science ®Google Scholar
• Azziz R, Woods KS, Reyna R, et al. The prevalence and features of the polycystic ovary syndrome in an unselected population. J Clin Endocrinol Metab. 2004;89(6):2745–2749.
   PubMed Web of Science ®Google Scholar
• Carmina E, Lobo RA. A comparison of the relative efficacy of antiandrogens for the treatment of acne in hyperandrogenic women. Clin Endocrinol. 2002;57(2):231–234.
   PubMed Web of Science ®Google Scholar
• Lai J-J, Chang P, Lai K-P, et al. The role of androgen and androgen receptor in skin-related disorders. Arch Dermatol Res. 2012;304(7):499–510.
   PubMed Web of Science ®Google Scholar
• Makrantonaki E, Ganceviciene R, Zouboulis C. An update on the role of the sebaceous gland in the pathogenesis of acne. Dermatoendocrinol. 2011;3(1):41–49.
   PubMedGoogle Scholar
• Ebede TL, Arch EL, Berson D. Hormonal treatment of acne in women. J Clin Aesthet Dermatol. 2009;2(12):16–22.
   PubMedGoogle Scholar
• Demirkan S, Sayın DB, Gündüz Ö. CAG polymorphism in the androgen receptor gene in women may be associated with nodulocystic acne. Postepy Dermatol Alergol. 2019;36(2):173–176.
   PubMed Web of Science ®Google Scholar
• Toyoda M, Morohashi M. Pathogenesis of acne. Med Electron Microsc. 2001;34(1):29–40.
   PubMedGoogle Scholar
• Lian N, Chen M. Metabolic syndrome and skin disease: potential connection and risk. Int J Dermatol Venereol. 2019;2(2):89–93.
   Google Scholar
• Brady C, Mousa SS, Mousa SA. Polycystic ovary syndrome and its impact on women's quality of life: more than just an endocrine disorder. Drug Healthc Patient Saf. 2009;1:9–15.
   PubMedGoogle Scholar
• Jalilian A, Kiani F, Sayehmiri F, et al. Prevalence of polycystic ovary syndrome and its associated complications in Iranian women: a meta-analysis. Iran J Reprod Med. 2015;13(10):591–604.
   PubMedGoogle Scholar
• Ghodsi SZ, Orawa H, Zouboulis CC. Prevalence, severity, and severity risk factors of acne in high school pupils: a community-based study. J Invest Dermatol. 2009;129(9):2136–2141.
   PubMed Web of Science ®Google Scholar
• Lynn DD, Umari T, Dunnick CA, et al. The epidemiology of acne vulgaris in late adolescence. Adolesc Health Med Ther. 2016;7:13–25.
   PubMed Web of Science ®Google Scholar
• Archer JS, Chang RJ. Hirsutism and acne in polycystic ovary syndrome. Best Pract Res Clin Obstet Gynaecol. 2004;18(5):737–754.
   PubMed Web of Science ®Google Scholar
• Andrade SCd, Previdelli ÁN, Cesar CLG, et al. Trends in diet quality among adolescents, adults and older adults: a population-based study. Prev Med Rep. 2016;4:391–396.
   PubMedGoogle Scholar